| Media, News, Press Release

【Successful Development of Pathology AI】Now Possible to Classify Gastric Poorly Differentiated Adenocarcinoma – Published in “Technology in Cancer Research & Treatment”

Medmain Inc., a provider of the digital pathology support solutions “PidPort”, has successfully developed a pathological AI that enables to classify gastric poorly differentiated adenocarcinoma in endoscopic submucosal dissection (ESD) whole slide images by using deep learning with weakly supervised learning (Deep Learning).

We are also pleased to announce that a paper on this development has been posted on “Technology in Cancer Research & Treatment” issued by SAGE Publishing ( , and published on December 7, 2022.

*This achievement was made possible by a grant from the New Energy and Industrial Technology Development Organization (NEDO).